PURPOSE/ OBJECTIVES: To compare treatment protocol adherence, satisfaction, and perceived changes in emotional and functional status between patients with lymphedema with and without cancer using the home-based Flexitouch (Tactile Systems Technology, Inc.) system for lymphedema self-care. DESIGN: Quasi-experimental, pre- and post-test design. SETTING: Private homes in the continental United States and Alaska. SAMPLE: 155 community-dwelling individuals with lymphedema: 93 with cancer-related lymphedema and 62 with noncancer-related lymphedema. METHODS: A survey was completed before use of the Flexitouch system. Participants received in-home education about device use, safety precautions, and the two-phase therapy protocol. A post-therapy survey was completed during the maintenance phase of the protocol. MAIN RESEARCH VARIABLES: Use of the Flexitouch system, treatment protocol adherence, participant satisfaction, and emotional and functional status. FINDINGS: Participants without cancer were more adherent to the prescribed protocol. Both groups were satisfied with the system, perceived it to be effective, and reported improvement in physical and emotional status. Participants' use of professional manual lymphatic drainage (MLD) therapy, self-MLD, and bandaging declined after they initiated use of the Flexitouch system. CONCLUSIONS: Patients using the Flexitouch system were satisfied with the device and perceived it to be beneficial in management of their lymphedema. IMPLICATIONS FOR NURSING: Patients using the Flexitouch system should be assessed for adherence to the prescribed treatment protocol and use of other self-care treatments. Healthcare professionals should facilitate communication among members of the lymphedema treatment team and the patient when problems are noted.
PURPOSE/ OBJECTIVES: To compare treatment protocol adherence, satisfaction, and perceived changes in emotional and functional status between patients with lymphedema with and without cancer using the home-based Flexitouch (Tactile Systems Technology, Inc.) system for lymphedema self-care. DESIGN: Quasi-experimental, pre- and post-test design. SETTING: Private homes in the continental United States and Alaska. SAMPLE: 155 community-dwelling individuals with lymphedema: 93 with cancer-related lymphedema and 62 with noncancer-related lymphedema. METHODS: A survey was completed before use of the Flexitouch system. Participants received in-home education about device use, safety precautions, and the two-phase therapy protocol. A post-therapy survey was completed during the maintenance phase of the protocol. MAIN RESEARCH VARIABLES: Use of the Flexitouch system, treatment protocol adherence, participant satisfaction, and emotional and functional status. FINDINGS:Participants without cancer were more adherent to the prescribed protocol. Both groups were satisfied with the system, perceived it to be effective, and reported improvement in physical and emotional status. Participants' use of professional manual lymphatic drainage (MLD) therapy, self-MLD, and bandaging declined after they initiated use of the Flexitouch system. CONCLUSIONS:Patients using the Flexitouch system were satisfied with the device and perceived it to be beneficial in management of their lymphedema. IMPLICATIONS FOR NURSING: Patients using the Flexitouch system should be assessed for adherence to the prescribed treatment protocol and use of other self-care treatments. Healthcare professionals should facilitate communication among members of the lymphedema treatment team and the patient when problems are noted.
Authors: Marek Ancukiewicz; Tara A Russell; Jean Otoole; Michelle Specht; Marybeth Singer; Alexandra Kelada; Colleen D Murphy; Jessica Pogachar; Valeria Gioioso; Megha Patel; Melissa Skolny; Barbara L Smith; Alphonse G Taghian Journal: Int J Radiat Oncol Biol Phys Date: 2010-06-03 Impact factor: 7.038
Authors: Jennifer K Doersam; Mary S Dietrich; Melissa A Adair; Bethany Rhoten; Jie Deng; Sheila H Ridner Journal: Lymphat Res Biol Date: 2019-08-05 Impact factor: 2.589
Authors: Kristen E Adams; John C Rasmussen; Chinmay Darne; I-Chih Tan; Melissa B Aldrich; Milton V Marshall; Caroline E Fife; Erik A Maus; Latisha A Smith; Renie Guilloid; Sunday Hoy; Eva M Sevick-Muraca Journal: Biomed Opt Express Date: 2010-07-15 Impact factor: 3.732